Recent events
Recent events tied to this brand in public sources.
Back to profile7 entries
2022
Nestlé Health Science completes acquisition of Vital Proteins
Nestlé Health Science completed its final acquisition of Vital Proteins, having acquired a majority stake in the brand in 2020.
2021
Nestlé Health Science and Healint initiate a virtual migraine study
Nestlé Health Science initiated a fully virtual study in Quebec to investigate whether a ketogenic nutritional supplement can reduce migraine attacks; the study uses a module within Healint’s Migraine Buddy app.
2021
Wavemaker and Nestlé Health Science jointly publish report installment
Wavemaker and Nestlé Health Science jointly published the fifth installment of the first season of their report series, “The Hidden Value of China’s Ageing Society.”
2021
Nestlé introduces bio-based lids and scoops for infant nutrition packaging
Nestlé and its nutrition businesses are introducing bio-based lids and scoops for infant nutrition products, including packaging for brands such as SMA, LITTLE STEPS, S-26, ILLUMA, Althéra, Alfaré, Alfamino, Modulen, and Peptamen Junior. The lids and scoops are made from sugar cane.
2020
Nestlé completes acquisition of Aimmune Therapeutics
Nestlé announced the successful completion of its acquisition of Aimmune Therapeutics, which joined Nestlé Health Science as a stand-alone business unit.
2020
Nestlé Health Science agrees to acquire a majority stake in Vital Proteins
Nestlé announced that Nestlé Health Science had agreed to acquire a majority stake in Vital Proteins. The transaction was pending regulatory approval; the amount was not disclosed.
2020
VALBIOTIS and Nestlé Health Science sign TOTUM-63 partnership
VALBIOTIS announced that it had signed a global strategic partnership with Nestlé Health Science to develop and commercialize TOTUM-63. The agreement grants Nestlé Health Science exclusive global commercial rights in the prediabetes and Type 2 Diabetes market and includes payments, royalties, and supply of TOTUM-63.